Human medicines European public assessment report (EPAR): Leflunomide Zentiva (previously Leflunomide Winthrop), leflunomide, Date of authorisation: 08/01/2010, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Xarelto, rivaroxaban, Date of authorisation: 30/09/2008, Revision: 43, Status: Authorised
Human medicines European public assessment report (EPAR): Icotyde, icotrokinra hydrochloride, Date of authorisation: 18/09/2026, Status: Authorised
Human medicines European public assessment report (EPAR): Zokovea, ensitrelvir, Date of authorisation: 18/09/2026, Status: Authorised
Human medicines European public assessment report (EPAR): Tacquell, Autologous melanoma-derived tumor infiltrating lymphocytes, ex vivo-expanded, Date of refusal: 14/09/2026, Status: Refused
CHMP opinions on consultation procedures on ancillary substances incorporated in a medical device
Agenda of the HMPC meeting 22-24 September 2026
Records of data processing activity Industry Single Point of Contact (i-SPOC) reporting system
European Medicines Agency’s privacy statement for the Industry Single Point of Contact (i-SPOC) system
Human medicines European public assessment report (EPAR): Yeytuo, lenacapavir, Date of authorisation: 25/08/2025, Revision: 3, Status: Authorised